Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases

Tianhong Pan, Eliza L.S. Fong, Mariane Martinez, Daniel A. Harrington, Sue Hwa Lin, Mary C. Farach-Carson, Robert L. Satcher

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Bone metastases from renal cell carcinoma (RCC) are typically lytic, destructive, and resistant to treatment regimens. Current in vitro models for studying metastasis introduce artifacts that limit their usefulness. Many features of tumors growing in bone are lost when human RCC cells are cultured in two-dimensional (2D) plastic substrata. In this study, we established that RCC spheroids, consisting of aggregates of cells, can be grown in a three-dimensional (3D) hyaluronate hydrogel-based culture system. The bone-derived human 786-O RCC subline proliferated and survived long term in these hydrogels. Additionally, RCC spheroids in 3D hydrogels demonstrated lower proliferation rates than their counterparts grown in 2D. Overall, gene expression patterns of RCC spheroids in 3D more closely mimicked those observed in vivo than did those of cells grown in 2D. Of particular importance, selected adhesion molecules, angiogenesis factors, and osteolytic factors that have been shown to be involved in RCC bone metastasis were found to be expressed at higher levels in 3D than in 2D cultures. We propose that the 3D culture system provides an improved platform for RCC bone metastasis studies compared with 2D systems.

Original languageEnglish (US)
Pages (from-to)89-95
Number of pages7
JournalCancer Letters
Volume365
Issue number1
DOIs
StatePublished - Aug 28 2015

Keywords

  • Bone metastasis
  • Hyaluronic acid
  • Hydrogel
  • Renal cell carcinoma
  • Three dimensional culture

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases'. Together they form a unique fingerprint.

Cite this